💠 Second-degree burns involve the epidermis and part of the dermis, making them deeper than superficial burns but not extending into subcutaneous tissue.

💠 They are characterized by blister formation, which results from separation between the epidermal and dermal layers due to tissue damage.

💠 The wound bed typically appears reddish-pink and moist, reflecting exposure of the underlying dermal tissue.

💠 These burns are associated with significant pain because nerve endings in the dermis remain intact and are exposed.

💠 Capillary refill is usually present, and the skin may blanch with pressure, distinguishing it from full-thickness burns.

Noting that blood vessels have clotted and can be seen under the burned skin

💠 Visible clotted vessels and a dry, leathery appearance are characteristic of third-degree (full-thickness) burns.

💠 These burns destroy nerve endings, often resulting in reduced or absent pain rather than extensive pain.

Extending into the subcutaneous tissue

💠 Burns extending into the subcutaneous tissue are classified as third-degree or fourth-degree burns.

💠 Second-degree burns do not penetrate into fat or muscle layers

Redness or pinkness noted but no blister formation is present on the epidermis

💠 First-degree burns affect only the epidermis and present with redness without blistering.

💠 These burns are typically dry and heal without scarring.

💠 Hypoxia results in decreased oxygen delivery to tissues, leading to visible cyanosis of the lips and nail beds when hemoglobin is poorly oxygenated.

💠 The brain is highly sensitive to oxygen deprivation, causing early symptoms such as restlessness, anxiety, and confusion.

💠 As oxygen levels continue to decline, neurological deterioration may progress to decreased level of consciousness and coma.

💠 Patients with COPD are especially vulnerable due to impaired gas exchange and chronic airflow limitation.

💠 These manifestations reflect systemic consequences of inadequate tissue oxygenation.

Aerobic metabolism will cease and anaerobic metabolism will take over, with formation and release of lactic acid

💠 When oxygen supply is insufficient, cells cannot sustain aerobic metabolism, which normally produces adequate ATP.

💠 The body shifts to anaerobic metabolism, resulting in significantly reduced energy production.

💠 This metabolic shift leads to accumulation of lactic acid, contributing to metabolic acidosis.

💠 Elevated serum lactate levels are clinical indicators of tissue hypoxia and poor perfusion.

💠 This process is a hallmark physiologic response in cases of severe hypoxemia.

There will be a decreased production of RBCs due to release of erythropoietin from the kidneys in response to hypoxia

💠 Hypoxia stimulates the kidneys to release erythropoietin, which increases red blood cell production rather than decreasing it.

💠 Chronic hypoxia in COPD often results in secondary polycythemia, not reduced RBC production.

SpO₂ level will be greater than 95% as measured by pulse oximetry

💠 Severe hypoxia is associated with decreased oxygen saturation levels, not readings above 95%.

💠 An SpO₂ greater than 95% generally indicates adequate oxygenation in most patients.

💠 ARDS causes diffuse alveolar damage, leading to increased permeability of the alveolar-capillary membrane and leakage of fluid into the alveoli.

💠 This results in formation of protein-rich pulmonary edema and hyaline membranes, which impair normal gas exchange.

💠 The lungs become stiff and noncompliant, meaning greater effort is required to expand them during inspiration.

💠 Decreased lung compliance increases the work of breathing, causing tachypnea and respiratory distress.

💠 Progressive hypoxemia occurs because collapsed and fluid-filled alveoli cannot effectively participate in oxygen diffusion.

Structural abnormalities of pulmonary vessels with proliferation of the vessel intima

💠 Proliferation of the pulmonary vessel intima is characteristic of pulmonary arterial hypertension, not ARDS.

💠 ARDS primarily involves alveolar and interstitial damage, not vascular structural remodeling.

Increases in left atrial pressure causing thickening of the lining of the pulmonary arteries

💠 Increased left atrial pressure is seen in cardiogenic pulmonary edema, not the non-cardiogenic process of ARDS.

💠 ARDS is defined by normal left atrial pressure with severe hypoxemia due to alveolar injury.

The elevation of pulmonary venous pressure

💠 ARDS results from inflammatory injury and increased capillary permeability, not venous pressure elevation.

💠 Emphysema causes destruction of alveolar walls, leading to loss of elastic recoil and inability of the lungs to fully deflate during expiration.

💠 Loss of elastic recoil results in air trapping, where residual air remains in the lungs after exhalation.

💠 Chronic air trapping leads to hyperinflation of the lungs, increasing total lung capacity over time.

💠 Hyperinflated lungs push the chest wall outward, producing an increased anterior-posterior (A-P) diameter, commonly called barrel chest.

💠 This structural change reflects long-standing chronic obstructive pathology, not an acute process.

Persistent coughing to remove mucous

💠 Persistent coughing is typically associated with chronic bronchitis, not the primary structural changes of emphysema.

💠 Coughing does not cause the anatomical chest wall expansion seen in barrel chest.

Dilated bronchi and increased mucous secretions

💠 Dilated bronchi are characteristic of bronchiectasis, not emphysema.

💠 Mucous hypersecretion contributes to airflow obstruction but does not directly cause barrel chest formation.

Recurrent damage to lung tissues

💠 Although tissue damage occurs in emphysema, barrel chest specifically results from air trapping and hyperinflation.

💠 Recurrent tissue damage alone does not explain the increase in A-P diameter without loss of elastic recoil.

💠 Hypermagnesemia depresses the central nervous system, leading to reduced neuromuscular excitability.

💠 Elevated magnesium levels inhibit acetylcholine release at the neuromuscular junction.

💠 This results in diminished deep tendon reflexes (hyporeflexia), which is an early clinical sign.

💠 As magnesium levels rise further, reflexes may become completely absent.

💠 Hyporeflexia is a classic manifestation of magnesium toxicity, especially in clients with renal insufficiency.

Muscle weakness causing shallow breathing

💠 Excess magnesium suppresses skeletal muscle contraction, leading to generalized muscle weakness.

💠 The diaphragm and intercostal muscles may be affected, causing shallow respirations.

💠 Severe hypermagnesemia can result in respiratory depression and potential respiratory failure.

💠 This occurs because magnesium acts as a physiologic calcium antagonist, impairing neuromuscular transmission.

💠 Respiratory compromise is a serious and life-threatening effect of elevated magnesium levels. Paresthesia of the lips

💠 Paresthesia around the lips is commonly seen in hypocalcemia, not hypermagnesemia.

💠 Magnesium excess typically causes neuromuscular depression rather than tingling sensations.

Blood pressure 180/90

💠 Hypermagnesemia commonly causes hypotension due to vasodilation.

💠 A blood pressure of 180/90 suggests hypertension, which does not correlate with magnesium toxicity.

Tetanic muscle contractions

💠 Tetany is a sign of hypocalcemia, characterized by increased neuromuscular excitability.

💠 Hypermagnesemia produces the opposite effect—reduced neuromuscular activity.

💠 Emphysema is a COPD phenotype marked by alveolar destruction and air trapping, which commonly produces tachypnea and an increased work of breathing (RR 32).

💠 Clients often have weight loss due to high energy expenditure from breathing and poor nutritional intake related to dyspnea.

💠 CO₂ retention can occur as ventilation becomes inefficient from loss of alveolar surface area and progressive airflow limitation.

💠 Symptoms such as chest tightness and dyspnea are consistent with hyperinflation and reduced elastic recoil.

💠 The age (64) fits the typical risk profile for emphysema, which is most often linked to long-term exposure to tobacco smoke or inhaled irritants.

15-year-old female with expiratory wheezing, chest tightness, and respiratory rate of 28

💠 A teenager with expiratory wheezing and chest tightness most strongly suggests asthma or reactive airway disease rather than emphysema.

💠 Emphysema is uncommon at this age unless a rare genetic cause is present, and the presentation here matches bronchospasm.

48-year-old female with septic shock, extreme dyspnea, frothy sputum, anxiety, Temp of 102, and respiratory rate of 38

💠 Frothy sputum and severe dyspnea in the setting of systemic illness and fever point more toward acute pulmonary edema or ARDS than emphysema.

💠 Emphysema is typically a chronic process and does not classically present with acute frothy sputum during septic shock.

56-year-old male with O₂ sat of 85%, recurrent productive cough, Temp of 101.1, and weight gain

💠 Recurrent productive cough with fever suggests chronic bronchitis exacerbation or respiratory infection, not emphysema-dominant COPD.

💠 Weight gain can be associated with fluid retention or reduced activity and does not fit the classic emphysema pattern of weight loss.

💠 Rheumatic heart disease is a delayed autoimmune complication of Group A β-hemolytic streptococcal infection, typically following untreated streptococcal pharyngitis.

💠 Detection of antistreptolysin O (ASO) titers or anti-DNase B antibodies confirms recent streptococcal exposure.

💠 The disease process results from molecular mimicry, where antibodies formed against streptococcal antigens cross-react with cardiac tissue.

💠 This immune-mediated reaction leads to inflammation of the heart valves (especially the mitral valve).

💠 Therefore, elevated Group A streptococcal antibodies directly support an immunologic cause, making this the most specific diagnostic aid.

High C-reactive protein levels

💠 C-reactive protein (CRP) indicates systemic inflammation but does not identify the underlying cause.

💠 CRP can be elevated in many infectious and inflammatory conditions unrelated to rheumatic fever.

Elevated white blood cell count

💠 An elevated WBC count suggests infection or inflammation but does not confirm an autoimmune post-streptococcal process.

💠 Leukocytosis is not specific to rheumatic heart disease.

Elevated erythrocyte sedimentation rate (ESR)

💠 ESR increases with inflammation but does not distinguish between infectious and autoimmune causes.

💠 It supports inflammation but does not specifically confirm rheumatic etiology.

💠 Coronary artery disease (CAD) is caused by narrowing or obstruction of the coronary arteries, which reduces blood flow to the myocardium.

💠 The primary underlying mechanism is atherosclerosis, characterized by plaque buildup composed of lipids, cholesterol, and inflammatory cells within the arterial walls.

💠 Progressive plaque formation leads to luminal narrowing and decreased oxygen supply to cardiac tissue.

💠 When myocardial oxygen demand exceeds supply, patients may experience angina or myocardial infarction.

💠 CAD is fundamentally a disease of impaired coronary blood flow, not increased flow or generalized pump failure.

The inability of the heart to pump adequate blood to the rest of the body

💠 This definition corresponds to heart failure, which involves reduced cardiac output.

💠 CAD can lead to heart failure, but it is not defined by pump failure itself.

A spectrum of heart diseases that affect blood flow to the heart

💠 While CAD affects blood flow, this statement is vague and does not identify atherosclerosis as the primary cause.

💠 CAD specifically refers to disease of the coronary arteries due to plaque formation.

Heart disease caused by increased coronary blood flow due to increased blood pressure

💠 CAD results from reduced coronary blood flow, not increased flow.

💠 Hypertension contributes to atherosclerosis but does not increase coronary perfusion in CAD.